Neuraxis, INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuraxis, INC. on April 22, 2026, covering events as of April 21, 2026. The company is incorporated in Delaware and trades on the NYSE American under the symbol NRXS. The filing primarily addresses an update to an existing At The Market (ATM) Offering Agreement.
Key Financial Metrics and Capital Activities
The filing details equity financing activities rather than operational financial performance metrics such as revenue or profit.
- ATM Offering Capacity: Increased from $6,270,000 to $11,500,000.
- Shares Sold (Aug 29, 2025 - Apr 20, 2026): 1,125,281 shares of Common Stock.
- Underwriter: Craig-Hallum Capital Group LLC.
- Registration Statement: Form S-3 (File No. 333-283798), effective February 11, 2025.
The filing text does not provide clear values for total proceeds generated from the shares sold, current cash balances, debt levels, or operating margins.
Material Changes
The primary material change is the amendment of the Prospectus Supplements to increase the aggregate offering price available under the ATM Agreement. Previously capped at $6,270,000, the company now has the capacity to sell up to $11,500,000 worth of common stock through the Sales Agent.
Outlook, Risks, and Management Commentary
Management has elected to increase the size of the ATM program, indicating a continued strategy to access public capital markets for liquidity or operational needs. The filing includes standard legal disclaimers stating that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful. No specific forward-looking guidance regarding revenue or earnings is provided in this document.
Key Facts for Investor Verification
- Verify the total dollar amount of proceeds actually received from the 1,125,281 shares sold between August 2025 and April 2026.
- Confirm the current cash position and burn rate to assess the necessity of the increased $11.5 million offering capacity.
- Review the latest quarterly report (10-Q) for operational metrics, as this 8-K contains no revenue or profit data.
- Check for any dilution impact on existing shareholders resulting from the expanded ATM program.